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Acute symptomatic hypoglycaemia mimicking
ischaemic stroke on imaging: a systemic review
Ai Wain Yong1, Zoe Morris1, Kirsten Shuler1, Colin Smith2 and Joanna Wardlaw1,3*
Abstract
Background: Acute symptomatic hypoglycaemia is a differential diagnosis in patients presenting with stroke-like
neurological impairment, but few textbooks describe the full brain imaging appearances. We systematically
reviewed the literature to identify how often hypoglycaemia may mimic ischaemic stroke on imaging, common
patterns and relationships with hypoglycaemia severity, duration, clinical outcome and add two new cases.
Methods: We searched EMBASE and Medline databases for papers reporting imaging in adults with symptomatic
hypoglycaemia. We analysed the clinical presentation, outcome, brain imaging findings, duration and severity of
hypoglycaemia, time course of lesion appearance, including two new cases.
Results: We found 42 papers describing computed tomography or magnetic resonance imaging in 65 patients,
plus our two cases with symptomatic hypoglycaemia. Imaging abnormalities on computed tomography and
magnetic resonance were uni or bilateral, cortical or sub-cortical. Thirteen (20%) mimicked cortical or lacunar stroke.
Acute lesions had restricted diffusion on magnetic resonance or low attenuation on computed tomography, plus
swelling; older lesions showed focal atrophy or disappeared, as with ischaemic stroke. The association between the
depth or duration of hypoglycaemia, the severity or extent of neurological deficit, and the imaging abnormalities,
was weak.
Conclusion: Imaging abnormalities in patients with hypoglycaemia are uncommon but very variable, weakly
associated with neurological deficit, and about a fifth mimic acute ischaemic stroke. Blood glucose testing should
be routine in all patients with acute neurological impairment and hypoglycaemia should be included in the
differential diagnosis of imaging appearances in patients presenting with acute stroke.
Keywords: Hypoglycaemia, Ischaemic stroke, MRI, CT, Lesions
Background
Hypoglycaemia, defined by a plasma glucose of <2.5
mmol/l (45 mg/dl), is the commonest endocrinological
emergency and causes a wide range of presenting neu-
rological symptoms including drowsiness, personality
change and seizures which mimic other conditions. The
neurological deficit may be focal, e.g. acute hemiplegia
[1], or global, e.g. coma, with symptoms potentially rever-
sible on restoration of normoglycaemia. The commonest
cause for symptomatic hypoglycaemia is inadvertent or
deliberate overdose with hypoglycaemic agents in known
diabetic patients. Less common causes of symptomatic
hypoglycaemia include insulin-secreting tumours, Addi-
son’s disease, renal or hepatic failure or severe sepsis. In
patients presenting with acute hemiparesis, if the diagno-
sis of hypoglycaemia is not considered, or routine blood
glucose measurement not performed, or the symptoms
fail to improve with glucose, then brain imaging may be
performed. Hypoglycaemia is a rare indication for neu-
roimaging and findings attributable to hypoglycaemia on
neuroimaging are infrequently described. There are few
published case reports on computed tomography (CT) or
magnetic resonance (MR) brain imaging in acute symp-
tomatic hypoglycaemia and little information available
from textbooks. An informal survey of senior neurora-
diologists across the UK (population covered approxi-
mately 40 million) revealed that only two were aware of
seeing a definite case of hypoglycaemia with imaging
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findings in recent years, contrasting with the daily im-
aging of several patients with stroke. Textbooks that do
mention imaging findings in hypoglycaemia typically de-
scribe bilateral cortical or subcortical changes on CT or
MR, but any description at all is missing from all stroke
textbooks that we have examined. Typical changes in-
clude brain tissue hypoattenuation on CT and increased
signal on T2-weighted (T2w), fluid-attenuated inversion
recovery, and diffusion-weighted images on MR. How-
ever, the time course, extent, cortical versus subcortical
involvement and relationship of imaging changes to
depth or duration of hypoglycaemia and symptoms are
lacking, with considerable scope for misdiagnosis. We
systematically review the literature to identify patterns of
imaging abnormalities, the relationship with neurological
findings and the depth and duration of hypoglycaemia
and determine how often hypoglycaemia might mimic
stroke on imaging, and present two cases of CT ab-
normality in acute symptomatic hypoglycaemia, one of
which was initially misdiagnosed as ischaemic stroke,
clinically and radiologically.
Methods
We searched EMBASE and Medline databases from
January 1970 to December 2010 for papers reporting
brain imaging with CT or MR in adults with symptom-
atic hypoglycaemia. We hand searched Stroke and Radi-
ology for additional papers and checked reference lists of
review articles. We included papers that provided any
imaging information in patients with hypoglycaemia. We
extracted information on clinical presentation including
severity of neurological deficit and duration of symp-
toms, time lapse since onset of hypoglycaemia if
known, depth and duration of hypoglycaemia, treatment
given, clinical outcome and imaging findings. From im-
aging, we extracted information on the type of imaging,
timing, whether findings were unilateral, bilateral, both
or midline, distribution (cortical or subcortical), size,
swelling, attenuation or signal change, contrast enhance-
ment, serial changes if available. We added similar data
from our two cases which we encountered while serving
as an expert witness for the UK Crown Prosecution
Service. We converted all blood glucose levels to mg/dl
(normal range 72 – 144 mg/dl). We tabulated the
extracted data and categorised the patients by severity
of neurological deficit and clinical outcome as: poor
clinical outcome (death, persistent vegetative state or
complete dependency); intermediate outcome (complete
physical recovery but significant persistent memory
deficits); or good outcome (complete recovery). We
described the distribution and extent of lesions on im-
aging by severity of hypoglycaemic injury, the time
course of the lesion appearance and effect of intraven-
ous contrast if given.
Results
The literature search yielded 42 papers describing imaging
of 65 patients with hypoglycaemia. Five papers described
CT imaging only [2-6], 21 papers described both CT and
MR [7-27], and 16 described MR only [28-43] (Table 1).
One paper described 17 patients, four papers described
between one and four patients and 37 papers described
only one patient. All case series were retrospective.
New cases
Our two new cases were both hospital inpatients re-
covering from hip replacement operations following
traumatic fractured neck of femur. In both cases, the pa-
tients were making a good recovery from surgery when
they were found unconscious in their beds by ward staff
at around 06.00 am. Both were noted to be profoundly
hypoglycaemic and blood glucose was rapidly returned
to normal and maintained in a normal range by intra-
venous glucose, despite which both patients died. The
further details are as follows. The first patient was an 86
year-old female with no significant past medical history.
Blood glucose measured approximately 30 minutes after
initial presentation was 0.5 mmol/l (9 mg/dl). Despite
returning the blood glucose to normal, the patient re-
mained comatose and was managed supportively. Thir-
teen days later, she was noted to have left sided weakness
by a consultant neurologist and was referred for CT
brain imaging (Figure 1) which demonstrated unilateral
right temporal and occipital cortical low attenuation
with loss of grey-white matter differentiation suggestive
of a subacute infarct. The right middle cerebral artery
(MCA) appeared hyperattenuated, suggestive of right
MCA thrombus and the patient was diagnosed as having
a right MCA territory ischaemic stroke, of uncertain re-
lationship to the profound hypoglycaemia. The patient
did not recover consciousness and died on day 22. Post-
mortem examination revealed bilateral neuronal loss,
gliosis and macrophage infiltration within the hippocam-
pus and in the lateral superficial cerebral cortex of the
right temporal and occipital regions consistent with a
diagnosis of cerebral injury due to hypoglycaemia and
not ischaemic. Mild arteriosclerosis was present but
there was no arterial thrombus. The second case was a
78 year-old female with no past history of note. Blood
glucose when found was 1.2 mmol/l (22 mg/dl) of max-
imum possible duration 6 hours. Despite returning the
blood glucose to normal, the patient failed to regain con-
sciousness. Brain CT performed within 9 hours of the
estimated time of induction of hypoglycaemia (Figure 2)
showed mild generalised cerebral swelling and reduc-
tion in grey-white matter differentiation in the temporal
and parietal regions bilaterally, worse on the right. The
patient died the following day. Post mortem was not
performed.
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Table 1 Summary of clinical and imaging findings from all papers describing brain imaging findings in hypoglycaemia
Author, Yeara Number
of cases
CT or MR Time to
scan
Uni or
bi-lateral
imaging
signs
Cortical
lesions
Deep
lesions
Lesion
enhancement
Cause of
hypo-glycaemia
Symptoms at
presentation
Outcome Lowest blood
glucose
Duration of
hypo-glycaemia
Severe neurological deficit and poor clinical outcome
Richardson,
1981 [42]
1 CT Day 1, Day 7,
Day 26
Bilateral Y N Y Unknown Coma Death 26mg/dl 12-24 hours
Iwai, 1987 [3] 1 CT Day 1, Day 3,
Day 5, Day 25
Unilateral Y N Y Insulin
overdose
Coma Vegetative 10 mg/dl 12-24 hours
Meer, 1988
[23] [French]
1 CT& MR Not recorded Bilateral N Y Y Insulin
overdose
Coma Persistent
hemiparesis
and dysphasia
Not recorded “Prolonged”
Berlit, 1990
[2][German]
1 CT Day 1, Day 3,
3 months
Bilateral Y Y Y Insulin
overdose
Coma Vegetative 60mg/dl 12-24 hours
Isono, 1993
[19] [Japanese]
1 CT & MR Day 2,
Day 4,
Day 9,
Day 16,
Day 23,
Day 82
Bilateral Y N Y ? Coma Vegetative ? Unknown
Boeve, 1995 [9] 1 CT & MR Day 1,
Day 3
Bilateral Y N N Insulin
overdose
Coma Persistent
severe
cognitive
impairment
and
seizures
(77 mg/dl
after
treatment)
Unknown
(probably
>24 hours)
Fujioka,
1997 [16]
4 CT & MR Multiple
studies,
Day 1 to
1 year
Bilateral Y Y Y Insulin
overdose (2);Oral
hypoglycaemic
agent overdose (2)
Coma Vegetative All <0.85 mmol/l
(<15mg/dl)
All 6–12 hours
Cubo, 1998
[13] [Spanish]
1 CT & MR Day 1, Day 7,
1 year
Bilateral N Y - Oral
hypoglycaemic
agent overdose
Coma Vegetative 28 mg/dl Unknown
Purucker,
2000 [5]
1 CT Day 1, Day 7 Bilateral N Y - Oral
hypoglycaemic
agent overdose
Coma Death ‘below the
detection
limit’
12-24 hours
Bakshi,
2000 [7]
1 CT & MR Day 2, Day 25 Bilateral N Y - Insulin overdose Coma Death (230 mg/dl
after
treatment)
>24 hours
Finelli,
2001 [15]
1 CT & MR Day 1, Day 4,
Day 5
Bilateral Y Y Y (basal
ganglia
lesions
only)
Insulin overdose Coma Death 23 mg/dl 12-24 hours
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Table 1 Summary of clinical and imaging findings from all papers describing brain imaging findings in hypoglycaemia (Continued)
Cheng, z
2001 [12]
1 CT & MR 1 week,
2 months
Bilateral N Y Y Not recorded
(diabetic)
Coma Vegetative Not recorded Not recorded
Chan, 2003 [11] 1 CT & MR Day 1 Bilateral Y N N Unknown
(insulin overdose
or insulin
receptor
antibodies)
Seizures;
coma
Death <20 mg/dl Unknown
Garambois,
2004 [17] [French]
1 CT & MR Day 1, Day 5,
Day 6, Day 27
Bilateral Y N - Insulin overdose
and alcohol
Coma Death <1 mmo/l
(<18mg/dl)
6-12 hours
Jung, 2005 [20] 1 CT & MR Day1, Day 3 Bilateral Y Y - Insulin overdose Coma Vegetative 33 mg/dl 6-12 hours
Yoneda,
2005 [27]
1 CT & MR Day 1, Day 22 Bilateral Y Y - Overdose of
insulin and oral
hypoglycaemic
agent
Coma Death [11.2mmol/l
(201mg/dl)
after treatment]
>24 hours
Lo, 2006 [34] 1 MR Day 6 Bilateral Y N - Oral
hypoglycaemic
agent overdose
Seizure; coma Death 2.1mmol/l
(38mg/dl)
<6 hours
Maekawa,
2006 [22]
1 CT & MR Day 1, Day 2
Day 7, Day 14,
Day 24
Bilateral Y N - Insulin overdose Coma Fully
dependent
36 mg/dl 12-24 hours
Mori, 2006 [24] 1 CT & MR Day 1,
2 weeks,
3 months
Bilateral Y Y - Insulin overdose Coma Death 27mg/dl 4 hours
Yanagawa,
2006 [26]
1 CT & MR Day 1, Day 5,
Day 50
Bilateral Y N - Insulin overdose Coma Fully
dependent
17mg/dl Unknown
Kim and Koh,
2007 [33]
1 MR Day 2 Bilateral N Y - Unknown
(diabetic)
Coma Death 14 mg/dl Unknown
Megarbane,
2007 [36]
1 MR Day 3, Day 30 Bilateral Y N - Insulin overdose Coma Death Not recordedb 6-12 hours
Roh, 2008 [39] 1 MR Day 7 Bilateral N Y N Unknown Coma Vegetative 25mg/dl Unknown
Ma, 2009 [42] 17 MR Day 1 Bilateral (15) Y (12) Y (10) - Insulin overdose
(8) Poor oral intake
in diabetic (6) Oral
hypoglycaemic
agent overdose (1)
Coma Vegetative
(14) Fully
dependent (1)
Range 15-40mg/dl Unknown
Tong and
Gong,
2009 [43]
1 MR Day 3 Bilateral Y Y - Oral
hypoglycaemic
agent overdose
Coma Death 20mg/dl 20-24 hours
Intermediate neurological severity and clinical outcome
Chalmers,
1991 [10]
1 CT& MR Day 1,
6 months
Unilateral Y N - Insulin overdose Coma Persistent
memory
impairment
1.8mmol/l
(32mg/dl)
6-12 hours
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Table 1 Summary of clinical and imaging findings from all papers describing brain imaging findings in hypoglycaemia (Continued)
Holemans,
2001 [18]
1 CT & MR Day 1,
Day 5
Bilateral Y N - Insulin overdose Somnolence Impaired
memory -
delayed
but full
recovery
Not recorded >24 hours
Batista, 2008 [8] 1 CT & MR Day 1 Bilateral Y N - Insulin overdose Coma Persistent
impaired
long-term
memory
34mg/dl 6-12 hours
Good clinical outcome
Koppel, 1993 [4] 1 CT Day 1, Day 2 Unilateral N Y N Insulin
overdose
Hemiparesis
then coma
Full recovery 40 mg/dl <6 hours
Endo, 2003
[14] [Japanese]
1 CT & MR Day 1 Bilateral N Y - ? Coma Full recovery ? ?
Okamoto,
2003 [37]
1 MR Day 1, Day 2 Bilateral N Y N Not recorded
(diabetic)
Coma Full recovery Not recorded Not
recorded
Aoki, 2004 [29] 1 MR Day 1, Day 10 Bilateral Y Y - Oral
hypoglycaemic
agent overdose
Coma Full recovery 20 mg/l 12-24 hours
Shirayama,
2004 [25]
1 CT & MR Day 1 Unilateral N Y - Insulin overdose Coma; Left
hemiparesis
Full recovery 0.9mmol/l
(16mg/dl)
5 hours
Bottcher,
2005 [30]
1 MR Day 1, Day 3 Bilateral (R>L) N Y - Oral
hypoglycaemic
agent overdose
Hemiparesis;
somnolent
Full recovery 1.71 mmol/l
(31mg/dl)
12-24 hours
Takeuchi, 2005
[40] [Japanese]
1 MR Day 1 Bilateral N Y - ? Coma Full recovery 28mg/dl <6 hours
Cordonnier,
2005 [31]
1 MR Day 1 Unilateral N Y - Pancreatic
tumour
Hemiparesis Full recovery 2.2 mmol/l
(40mg/dl)
<6 hours
Doherty,
2005 [32]
2 MR Day 1 Bilateral N Y - Insulin
overdose and
alcohol
Somnolence Full recovery 57mg/dl Unknown
MR Day 1 Bilateral N Y - Insulin
overdose
Coma Full recovery (56mg/dl after
treatment)
Unknown
Pandian,
2005 [38]
1 MR Day 1 Midline N Y - Unknown
(diabetic)
Coma Full recovery Not recorded Unknown
Lo, 2006 [34] 1 MR Day 1
(45 minutes;
12 hours)
Bilateral N Y - Oral
hypoglycaemic
agent overdose
Coma Full recovery 1.9mmol/l
2(34mg/dl)
<2 hours
Albayram,
2006 [28]
1 MR Day 1 Unilateral N Y - Insulin-secreting
liver metastsis
Hemiparesis Full recovery 32mg/dl 6 hours
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Table 1 Summary of clinical and imaging findings from all papers describing brain imaging findings in hypoglycaemia (Continued)
Kim et al.,
2007 [21]
3 MR Day 1 Unilateral N Y - Oral
hypoglycaemic
agent overdose
Somnolent;
hemiparesis
Full recovery 38mg/dl 8 hours
CT & MR Day 1, Day 3 Midline N Y - Insulin overdose Somnolent Full recovery 21mg/dl Unknown
CT & MR Day 1, Day 9 Midline N Y - Insulin overdose Coma; seizures Full recovery 3mg/dl 8 hours
Maruya,
2007 [35]
1 MR Day 1, Day 3 Bilateral N Y - Oral
hypoglycaemic
agent overdose
Coma Full recovery 1.8 mmol/l
(32mg/dl)
Unknown
Terakawa,
2007 [41]
1 MR Day 1, Day 2 Unilateral
and midline
N Y - Insulin overdose Hemiparesis Full recovery 24mg/dl 6-12 hours
Ma, 2009 [42] 2 MR Day 1 Midline (1) N Y - Poor oral
intake in diabetic
Somnolent Full recovery Unknown
Unilateral (1) N Y - Unknown Somnolent Full recovery Unknown
aSome studies appear more than once if they provided data on patients in more than one category.
bIndividual’s data not recorded. Presented as part of a subgroup where n=4, with median blood glucose 0.7mmol/l (range 0.5 - 4.1mmol/l) (12mg/dl, range 9-73mg/dl).
CT - computed tomography; MR - magnetic resonance.
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Literature survey
Patients with severe neurological deficit and poor clinical
outcome
46 in total, presented with coma and had poor outcome of
death [5,7,11,15,17,24,27,34,36,43], persistent vegetative
state [2,3,12,13,16,19,20,39,42], or limited recovery with
severe long-term neurological deficits [9,22,23,26,42].
Where recorded, glucose levels at presentation ranged
from 10 mg/dl to 60 mg/dl (mean 24 mg/dl), and dur-
ation of hypoglycaemia was greater than 6 hours in all
but two cases [24,34]. The majority had bilateral, gen-
erally symmetrical areas of reduced attenuation on CT
or of high signal on T2 or diffusion-weighted imaging
(DWI) and restricted diffusion on MR, i.e. similar at-
tenuation or signal changes to acute ischaemia (Figure 3).
Generalised cerebral swelling was also described
[6,16,17,19,26]. Lesions were typically distributed in the
basal ganglia [7,11-13,15,16,20,23,26,39,42], or cerebral
cortex [2,3,6,9,11,15-17,19,20,22,24,26,27,34,36,42], with
some involvement of the hippocampi [7,9,13,15-17,22,42].
Cortical lesions were seen more frequently in the occipital
and temporal lobes [2,3,6,9,11,15-17,19,20,22,24,27,34],
but frontal and parietal cortical lesions also occurred ei-
ther in addition to [6,11,16,19,20,27,34,42,43] or in the
absence of temporal and occipital cortical lesions
[26,36,42]. Occasional patients had unilateral cortical ab-
normalities [17] like our Case 1, difficult to distinguish
from ischaemic stroke. Other less common patterns
included bilateral diffuse periventricular restricted diffu-
sion [5,24,27,33,42], diffuse cortical diffusion restriction
[24], or large pontine lesions [5]. All patients who sur-
vived and had follow-up imaging at least 25 days after
the acute hypoglycaemic episode showed diffuse cerebral
atrophy [2,3,6,12,13,16,17,19,24,26,36].
Patients with intermediate neurological severity and clinical
outcome
These few patients (n=3) all presented with hypogly-
caemic coma and achieved generally good recovery after
treatment but had persistent short-term memory deficits.
Where recorded, glucose levels at presentation ranged
a b
Figure 1 86 year old female in hypoglycaemic coma, computed tomography on Day 14 after onset of hypoglycaemia. There is a large
area of low attenuation involving grey and white matter in the right temporal and parietal lobes. Differential diagnosis for this imaging
appearance would be acute right middle and posterior cerebral artery territory infarction.
a
b
c
d
Figure 2 78 year old female in hypoglycaemic coma, computed
tomography performed approximately 9 hours after onset of
hypoglycaemia. There are areas of cortical low attenuation and
swelling in the temporal and parietal lobes bilaterally.
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from 32 mg/dl – 34 mg/dl (mean 33 mg/dl). Duration of
hypoglycaemia was between 6 and 12 hours in two patients
and more than 24 hours in the third patient [8,10,18]. Two
case reports described unilateral [10] or bilateral [18] hippo-
campal abnormalities with increased signal on T2w MR. A
third patient [8] had bilateral widespread cortical and hippo-
campal T2w high signal at presentation which was unusual in
that all other patients with this imaging pattern had poor clin-
ical outcome (death [17] or long-term severe disability [9,22]).
Patients with good clinical outcome
These patients (n=24) presented with coma (13 pa-
tients), acute hemiparesis and somnolence (9 patients)
or acute hemiparesis followed by coma (2 patients) but
all recovered completely upon correction of blood glucose,
usually within hours of symptom onset. Where recorded,
glucose levels at presentation ranged from 3 mg/dl –
57 mg/dl (mean 29 mg/dl), and duration of hypogly-
caemia was greater than 6 hours in six and less than
6 hours in five patients from the 11 studies that pro-
vided this information. Lesions were all low attenua-
tion on CT or showed restricted diffusion on apparent
diffusion coefficient mapping or high signal on T2w
imaging on MR (Figure 4). Most lesions were bilateral
[14,21,28-30,32,34,35,37] but seven patients had uni-
lateral [4,25,31,41] lesions mimicking stroke. Lesions
a 
b 
c 
d e 
Figure 3 The patterns of abnormality which have been described in cases of acute symptomatic hypoglycaemia with poor outcome
(death, persistent vegetative state, or severe long-term neurological deficit) – 3c is similar to New Case 1, the hypoattenuation being
predominantly unilateral. All used with permission: a [39], b [15], c [3], d [33], e [5].
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were located anywhere along the corticospinal tracts,
including the motor cortex [29], corona radiate
[29,30,34,42], posterior limb of the internal capsule
[4,14,21,28,29,31,32,34,35,41], pyramidal tracts [25,37],
splenium of the corpus callosum [21,30,32,34,35,41] or
middle cerebellar peduncles [32,37]. A few patients had
isolated lesions in the splenium [38,40,42]. Patients with
unilateral lesions more often presented with hemiparesis
mimicking stroke, with only one patient presenting in
coma [25]. Those with bilateral lesions were more likely
to present with coma, although two with asymmetrical
internal capsule lesions presented with hemiparesis
[28,30]. Where neuroimaging was repeated after symp-
tom recovery (all within 3 days of presentation), there
was either complete [4,14,21,25,30-32,34,35,37,40,41] or
partial [28,29] resolution of the imaging abnormalities.
Time course of lesion appearance
was similar to that of ischaemic stroke. Amongst the 55
patients (34 papers) imaged on the day of admission,
lesions were seen on MR DWI as early as 45 minutes
after symptom onset [25,31,34,35,41], but were not ap-
parent on T2w imaging until at least 12 hours after
symptom onset [8,11,37,38]. Of the 21 CTs performed
on the day of admission, only one showed a low attenu-
ation lesion [4], whilst two showed generalised cerebral
swelling [17,26]. Eighteen patients had normal CT ap-
pearances, including 5 with abnormal MR imaging on
the same day [11,21,25,27]. The second new patient that
we present (Figure 2) was imaged within 9 hours of
symptom onset, showed mild generalised cerebral swel-
ling and bilateral patchy reduction in grey matter attenu-
ation. Amongst patients imaged sequentially with CT,
a 
b c 
Figure 4 The patterns of abnormality seen in cases of symptomatic acute hypoglycaemia with good outcome (complete recovery)
– b and c mimic lacunar stroke on imaging. All used with permission: a [29], b [31], c [25].
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lesions became more apparent on day 2 or thereafter
[2,3,5,6,9,13,15-18,20,22,26]. Our first new case, imaged
at 14 days after initial presentation, showed unilateral
cortical low attenuation and swelling. Patients with good
clinical outcome who had repeat imaging showed reso-
lution of lesions as early as 6 hours after clinical recovery
[4,21,28-31,34,35,37,40,41]. Patients with intermediate
outcome showed no lesion resolution. Only three cases
with poor clinical outcome showed lesion resolution
[22,26,36], after 14, 50 and 30 days respectively. General-
ised cerebral atrophy was present in all 11 patients with
poor outcome and follow-up imaging at least 25 days
after admission [2,3,6,12,13,16,17,19,24,26,36].
Contrast enhancement
Sixteen patients received intravenous contrast, 10 on CT
examination [2-4,6,16,19,23] and 6 on MR [9,11,12,15,37,39].
Of these, 11 showed enhancement either of cortical
[2,3,6,16,19] or basal ganglia [12,15,16,23] lesions, be-
tween the 2nd and 14th day after presentation. Of seven
patients receiving contrast later, three (performed on
days 23, 25 and 26 after presentation) showed lesion en-
hancement [3,6,16,19].
Discussion
Acute hypoglycaemia may mimic acute ischaemic stroke
on brain imaging, in about 20% of cases reported in the
literature, by causing either unilateral cortical and adja-
cent subcortical tissue hypoattenuation and swelling
greater than cortical ischaemic stroke (e.g. Case 1), or la-
cunar ischaemic stroke (e.g. Figure 4b). Usually the di-
agnosis of hypoglycaemia would be obvious, but in
patients with hemiparesis, unilateral imaging findings
could be mistaken for ischaemic stroke. Brain imaging
changes in acute symptomatic hypoglycaemia are not al-
ways diffuse or bilateral. The literature suggests that the
less severe episodes of hypoglycaemia are more likely to
cause hemiparesis and smaller corticospinal tract lesions
on imaging, thus may be more likely to mimic ischaemic
stroke. These are also likely to be clinically milder
strokes or transient ischaemic attacks (TIAs). Alterna-
tively, it may be that hypoglycaemia can cause lesions in
a wide range of brain regions but that only those in the
corticospinal tracts cause focal neurological symptoms
(hemiparesis or hemisensory loss) sufficient to trigger
scanning because of the clinical similarity to stroke. Al-
though T2 changes, restricted diffusion and CT atten-
uation changes are consistent with ischaemia, the
pathology is rather different. Clues to the true diagnosis
are that the lesion may not conform strictly to an arterial
territory and the slightly different time course to ischae-
mic stroke, e.g. the persistence of swelling at 14 days in
our Case 1, although here the duration of the left-sided
weakness was unclear as it was only noticed sometime
after the onset of hypoglycaemia and was hard to pin-
point as the patient was in a coma. Cases mimicking la-
cunar stroke may have lesions that appear identical to
acute lacunar infarction on diffusion-weighted MR im-
aging [25]. The signal/attenuation changes can disappear
rapidly. Therefore, as standard practice, plasma glucose
should be measured in all patients with suspected acute
ischaemic stroke to ensure correct diagnosis and prompt
treatment of hypoglycaemia. Hypoglycaemia should be
part of the differential diagnosis of patients presenting
with clinical or imaging features of stroke or TIA.
The literature summary indicates that hypoglycaemia
duration rather than depth was related to clinical out-
come, prolonged hypoglycaemia resulting in poor out-
come, in agreement with one prospective study [36]. In
general, the more severe the symptoms, the more exten-
sive the bilateral cortical involvement with persistent
long-term brain damage. The less severe the symptoms,
the imaged abnormalities were more likely unilateral and
distributed along the motor pathway, with resolution of
lesions. The new cases that we present fell into the poor
outcome group with Case 2 fitting the most frequently
described pattern of patchy bilateral cortical abnormal-
ity, whilst Case 1 fitted the less typical pattern of unilat-
eral confluent cortical abnormality mimicking cortical
ischaemic stroke. The proportion of patients with hypo-
glycaemia who develop imaging abnormalities, and the
proportion of those that mimic ischaemic stroke, are un-
known as there are no prospective and complete series
of patients with hypoglycaemia all of whom had brain
imaging. The largest case series (n=17) [42], mostly pa-
tients with poor outcome, was consistent with the other
40 papers, namely that duration but not degree of hypo-
glycaemia was related to both clinical outcome and ex-
tent of imaging lesions. However, the paucity of patients
with mild, transient symptoms or unilateral imaging
lesions suggests that their retrospective case identifica-
tion may have overlooked patients with mild hypogly-
caemia, some of whom may masquerade as TIA.
Conclusions
Hypoglycaemia, from any cause, of any severity or dur-
ation may mimic ischaemic stroke neurologically and on
CT or MR brain imaging. Hypoglycaemia should always
be considered in the differential diagnosis, albeit rare, of
acute focal neurological symptoms and excluded using
routine blood glucose testing.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
AWY performed literature research, participated in the experimental studies
and data analysis, and edited the manuscript. ZM performed literature
research, participated in the experimental studies and data analysis,
performed statistical analysis, prepared the manuscript, and edited the
Yong et al. BMC Neurology 2012, 12:139 Page 10 of 12
http://www.biomedcentral.com/1471-2377/12/139
manuscript. KS performed statistical analysis and prepared the manuscript.
CS performed clinical studies and participated in the experimental studies
and data analysis, and edited the manuscript JMW is guarantor of integrity
of the entire study, conceived of the study concepts and design, performed
literature research, performed clinical studies, participated in the
experimental studies and data analysis, edited the manuscript, and approved
final version for submission. All authors read and approved the final
manuscript.
Acknowledgements
The two new scans presented here were encountered while one of the
authors was serving as an expert witness for the UK Crown Prosecution
Service. Permissions for use and reproduction of all figures in print and
electronic formats have been granted.
Author details
1Division of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.
2Department of Neuropathology, Western General Hospital, Edinburgh, UK.
3Neuroradiology, Bramwell Dott Building, Division of Clinical Neurosciences,
University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, UK.
Received: 26 July 2012 Accepted: 14 November 2012
Published: 21 November 2012
References
1. Wallis WE, Donaldson I, Scott RS, Wilson J: Hypoglycemia masquerading as
cerebrovascular disease (hypoglycemic hemiplegia). Ann Neurol 1985,
18:510–512.
2. Berlit P, Buss J, Pohlmann-Eden B: [Bitemporal CT hypodensity in
hypoglycaemia]. Aktuelle Neurologie 1990, 17:22–23.
3. Iwai A, Sakamoto T, Kinoshita Y, Yokota J, Yoshioka T, Sugimoto T:
Computed tomographic imaging of the brain in after hypoglycemia
coma. Neuroradiology 1987, 29:398–400.
4. Koppel BS, Daras M: Transient hypodensity on CT scan during
hypoglycemia. Eur Neurol 1993, 33:80–82.
5. Purucker E, Nguyen HN, Lammert F, Koch A, Matern S: Central pontine
myelinolysis and myocardial infarction following severe hypoglycemia.
Intensive Care Med 2000, 26:1406–1407.
6. Richardson ML, Kinard RE, Gray MB: CT of generalized gray matter
infarction due to hypoglycemia. AJNR Am J Neuroradiol 1981, 2:366–367.
7. Bakshi R, Morcos MF, Gabryel TF, Dandona P: Is fluid-attenuated inversion
recovery MRI more sensitive than conventional MRI for hypoglycemic
brain injury? Neurology 2000, 55:1064–1065.
8. Batista MS, Almeida KJ, Avelino MC, Borges LM: Hemiparesis and
lateralized cortical lesions associated to severe hypoglycemia. Arq
Neuropsiquiatr 2008, 66:101–103.
9. Boeve BF, Bell DG, Noseworthy JH: Bilateral temporal lobe MRI changes in
uncomplicated hypoglycemic coma. Can J Neurol Sci 1995, 22:56–58.
10. Chalmers J, Risk MT, Kean DM, Grant R, Ashworth B, Campbell IW: Severe
amnesia after hypoglycemia. Clinical, psychometric, and magnetic
resonance imaging correlations. Diabetes Care 1991, 14:922–925.
11. Chan R, Erbay S, Oljeski S, Thaler D, Bhadelia R: Case report: hypoglycemia
and diffusion-weighted imaging. J Comput Assist Tomogr 2003,
27:420–423.
12. Cheng SJ, Hsueh IH, Po HL, Huang JK, Tzen CY, Huang FC: Neuroimaging
characteristics of basal ganglia lesions in diabetic patients: correlation
with clinical features. Acta Neurol Taiwan 2001, 10:14–20.
13. Cubo E, Andres MT, Rojo A, Guerrero A, Urra DG, Mendez R: [Neuroimaging
of hypoglycemia]. Rev Neurol (Paris) 1998, 26:774–776.
14. Endo H, Shimizu H, Tominaga T, Yoshimoto T: [Transient hyperintensity
lesions on diffusion-weighted MRI in the bilateral internal capsules due
to hypoglycemic coma]. No To Shinkei 2003, 55:174–175.
15. Finelli PF: Diffusion-weighted MR in hypoglycemic coma. Neurology 2001,
57:933–935.
16. Fujioka M, Okuchi K, Hiramatsu KI, Sakaki T, Sakaguchi S, Ishii Y: Specific
changes in human brain after hypoglycemic injury. Stroke 1997,
28:584–587.
17. Garambois K, Grand S, Jaillard A, Hommel M: [Diffusion-weighted magnetic
resonance imaging in hypoglycemic coma]. Rev Neurol (Paris) 2004,
160:575–578.
18. Holemans X, Dupuis M, Misson N, Vanderijst JF: Reversible amnesia in a
Type 1 diabetic patient and bilateral hippocampal lesions on magnetic
resonance imaging (MRI). Diabet Med 2001, 18:761–763.
19. Isono O, Araki S, Shiota J, Toyota S, Sugita K: [Hypoglycemic
encephalopathy demonstrating generalized multiple cortical infarctions-
sequential CT findings]. No To Shinkei 1993, 45:1061–1066.
20. Jung SL, Kim BS, Lee K-S, Yoon KH, Byun JY: Magnetic resonance imaging
and diffusion-weighted imaging changes after hypoglycemic coma:
J Neuroimaging 2005, 15:193–196.
21. Kim JH, Choi JY, Koh SB, Lee Y: Reversible splenial abnormality in
hypoglycemic encephalopathy: Neuroradiology 2007, 49:217–222.
22. Maekawa S, Aibiki M, Kikuchi K, Kikuchi S, Umakoshi K: Time related
changes in reversible MRI findings after prolonged hypoglycemia.
Clin Neurol Neurosurg 2006, 108:511–513.
23. Meer A, Dubois B, Dormont D, Grimaldi A: [Value of magnetic resonance
imaging after severe hypoglycemic coma]. Presse Med 1988,
17:1368.
24. Mori F, Nishie M, Houzen H, Yamaguchi J, Wakabayashi K: Hypoglycemic
encephalopathy with extensive lesions in the cerebral white matter.
Neuropathology 2006, 26:147–152.
25. Shirayama H, Ohshiro Y, Kinjo Y, Taira S, Teruya I, Nakachi K, Tawata M,
Takasu N: Acute brain injury in hypoglycaemia-induced hemiplegia.
Diabet Med 2004, 21:623–624.
26. Yanagawa Y, Isoi N, Tokumaru AM, Sakamoto T, Okada Y: Diffusion-
weighted MRI predicts prognosis in severe hypoglycemic
encephalopathy. J Clin Neurosci 2006, 13:696–699.
27. Yoneda Y, Yamamoto S: Cerebral cortical laminar necrosis on
diffusion-weighted MRI in hypoglycaemic encephalopathy. Diabet Med
2005, 22:1098–1100.
28. Albayram S, Ozer H, Gokdemir S, Gulsen F, Kiziltan G, Kocer N, Islak C:
Reversible reduction of apparent diffusion coefficient values in bilateral
internal capsules in transient hypoglycemia-induced hemiparesis. AJNR
Am J Neuroradiol 2006, 27:1760–1762.
29. Aoki T, Sato T, Hasegawa K, Ishizaki R, Saiki M: Reversible hyperintensity
lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology 2004,
63:392–393.
30. Bottcher J, Kunze A, Kurrat C, Schmidt P, Hagemann G, Witte OW, Kaiser
WA: Localized reversible reduction of apparent diffusion coefficient in
transient hypoglycemia-induced hemiparesis Stroke 2005, 36:e20–e22.
31. Cordonnier C, Oppenheim C, Lamy C, Meder JF, Mas JL: Serial diffusion
and perfusion-weighted MR in transient hypoglycemia. Neurology 2005,
65:175.
32. Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK: Clinical
implications of splenium magnetic resonance imaging signal changes.
Arch Neurol 2005, 62:433–437.
33. Kim JH, Koh SB: Extensive white matter injury in hypoglycemic coma.
Neurology 2007, 68:1074.
34. Lo L, Tan AC, Umapathi T, Lim CC: Diffusion-weighted MR imaging in
early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol
2006, 27:1222–1224.
35. Maruya J, Endoh H, Watanabe H, Motoyama H, Abe H: Rapid improvement
of diffusion-weighted imaging abnormalities after glucose infusion in
hypoglycemic coma. J Neurol Neurosurg Psychiatry 2007, 78:102–103.
36. Megarbane B, Deye N, Bloch V, Sonneville R, Collet C, Launay JM, Baud FJ:
Intentional overdose with insulin: prognostic factors and
toxicokinetic/toxicodynamic profiles. Crit Care 2007, 11:R115.
37. Okamoto K, Tokiguchi S, Furusawa T, Ishikawa K, Quardery AF, Shinbo S,
Sasai K: MR features of diseases involving bilateral middle cerebellar
peduncles. AJNR Am J Neuroradiol 2003, 24:1946–1954.
38. Pandian JD, Henderson RD: Boomerang sign" in the splenium of the
corpus callosum. Med J Aust 2005, 183:628.
39. Roh JH, Park KW, Kim BJ: Deep gray matter lesion caused by
hypoglycemia. Am J Phys Med Rehabil 2008, 87:249–250.
40. Takeuchi S: [Reversible increased signal intensities in the splenium on
diffusion-weighted imaging caused by transient hypoglycemia]. No To
Shinkei 2012, 57:420–421.
41. Terakawa Y, Tsuyuguchi N, Nunomura K, Murayama N, Fujishige M,
Yamamura A, Nakagawa T, Hashi K: Reversible diffusion-weighted imaging
changes in the splenium of the corpus callosum and internal capsule
associated with hypoglycemia - case report. Neurol Med Chir (Tokyo) 2007,
47:486–488.
Yong et al. BMC Neurology 2012, 12:139 Page 11 of 12
http://www.biomedcentral.com/1471-2377/12/139
42. Ma J-H, Kim Y-J, Yoo W-J, Ihn Y-K, Kim J-Y, Song H-H, Kim B-S: MR imaging
of hypoglycemic encephalopathy: lesion distribution and prognosis
prediction by diffusion-weighted imaging. Neuroradiology 2009,
51:641–649.
43. Tong D, Gong Y: What causes irreversible prolonged coma after severe
hypoglycaemia? Diabet Med 2009, 26:749–750.
doi:10.1186/1471-2377-12-139
Cite this article as: Yong et al.: Acute symptomatic hypoglycaemia
mimicking ischaemic stroke on imaging: a systemic review. BMC
Neurology 2012 12:139.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yong et al. BMC Neurology 2012, 12:139 Page 12 of 12
http://www.biomedcentral.com/1471-2377/12/139
